The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Targeted drug delivery via folate receptors
Abstract
Targeted delivery via selective cellular markers can potentially increase the efficacy and reduce the toxicity of therapeutic agents. The folate receptor (FR) has two glycosyl phosphatidylinositol (GPI)-anchored isoforms, alpha and beta. FR-alpha expression is frequently amplified in epithelial cancers, whereas FR-beta expression is found in myeloid leukemia and activated macrophages associated with chronic inflammatory diseases. Conjugates of folic acid and anti-FR antibodies can be taken up by cancer cells via receptor-mediated endocytosis, thus providing a mechanism for targeted delivery to FR+ cells. The aim of this article is to provide a brief overview of applications of FR targeting in drug delivery, with an emphasis on the strategy of using folate as a targeting ligand. In order to do this, recent literature is surveyed on targeted delivery via both FR sub-types, as well as new findings on selective receptor upregulation in the targeted cells. A wide variety of molecules and drug carriers, including imaging agents, chemotherapeutic agents, oligonucleotides, proteins, haptens, liposomes, nanoparticles and gene transfer vectors have been conjugated to folate and evaluated for FR-targeted delivery. Substantial targeting efficacy has been found both in vitro and in vivo. In addition, mechanisms and methods for selective FR upregulation have been uncovered, which might enhance the effectiveness of the FR-targeted delivery strategy. FR-alpha serves as a useful marker for cancer, whereas FR-beta serves as a marker for myeloid leukemia and chronic inflammatory diseases. FR-targeted agents have shown promising efficacy in preclinical models and significant potential for future clinical application in a wide range of diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted drug delivery via the folate receptor
Sudimack, J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,474
Self-citationDistribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
Lee, R. J., & Low, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41848-5 · Cited by 692
Self-citationElnakat, H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.001 · Cited by 649
Majoros, I. J., Myc, A., Thomas, T., Mehta, C. B., & Baker, J. R. (2006) · Biomacromolecules · doi:10.1021/bm0506142 · Cited by 596
Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro
Lee, R. J., & Low, P. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00235-h · Cited by 574
Self-citationLeamon, C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.008 · Cited by 558
Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.
Leamon, C. P., & Low, P. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5572 · Cited by 554
Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA–PEG block copolymer
Yoo, H. S., & Park, T. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00340-0 · Cited by 538
Overexpression of folate binding protein in ovarian cancers
Toffoli, G., Cernigoi, C., Russo, A., Gallo, A., Bagnoli, M., & Boiocchi, M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970422)74:2<193::aid-ijc10>3.0.co;2-f · Cited by 521
Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., & Zalipsky, S. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9801124 · Cited by 468
Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M., Zalipsky, S., & Gabizón, A. (2000) · PubMed · Cited by 468
Targeted gene delivery by tropism-modified adenoviral vectors
Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M., & Curiel, D. T. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1574 · Cited by 428
Lee, R. J., & Huang, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8481 · Cited by 397
Self-citationChan, P., Kurisawa, M., Chung, J. E., & Yang, Y.-Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.08.046 · Cited by 358
Miotti, S., Canevari, S., Ménard, S., Mezzanzanica, D., Porro, G., Pupa, S. M., Regazzoni, M., Tagliabue, E., & Colnaghi, M. I. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390306 · Cited by 315
In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizón, A., Horowitz, A. T., Goren, D., Tzemach, D., Shmeeda, H., & Zalipsky, S. (2003) · PubMed · Cited by 295
Paulos, C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.012 · Cited by 290
Park, E. K., Lee, S. B., & Lee, Y. M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.04.008 · Cited by 264
Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G., & Low, P. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3318 · Cited by 256
Self-citationFolate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential
Lu, Y. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.009 · Cited by 256
Nakashima-Matsushita, N., Homma, T., Yu, S., Matsuda, T., Sunahara, N., Nakamura, T., Tsukano, M., Ratnam, M., & Matsuyama, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1609::aid-anr7>3.0.co;2-l · Cited by 251
Choi, H., Choi, S. R., Zhou, R., Kung, H. F., & Chen, I.-W. (2004) · Academic Radiology · doi:10.1016/j.acra.2004.04.018 · Cited by 240
Lacey, S. W., Sanders, J. M., Rothberg, K. G., Anderson, R. G., & Kamen, B. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114220 · Cited by 238
Shen, F., Ross, J. F., Wang, X., & Ratnam, M. (1994) · Biochemistry · doi:10.1021/bi00171a021 · Cited by 231
Ross, J. F., Wang, H., Behm, F. G., Mathew, P., Wu, M., Booth, R., & Ratnam, M. (1999) · Cancer · Cited by 225
A folate receptor-targeted liposomal formulation for paclitaxel
Wu, J., Liu, Q., & Lee, R. J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.027 · Cited by 212
Self-citationPan, X. Q., Zheng, X., Shi, G., Wang, H., Ratnam, M., & Lee, R. J. (2002) · Blood · doi:10.1182/blood.v100.2.594 · Cited by 200
Self-citationHomologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA
Ratnam, M., Marquardt, H., Duhring, J. L., & Freisheim, J. H. (1989) · Biochemistry · doi:10.1021/bi00446a042 · Cited by 200
Folate-Targeted PEG as a Potential Carrier for Carboplatin Analogs. Synthesis and in Vitro Studies
Aronov, O., Horowitz, A. T., Gabizon, A., & Gibson, D. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025642l · Cited by 198
Endocytosis of folate-protein conjugates: ultrastructural localization in kb cells
Turek, J. J., & Low, P. S. (1993) · Journal of Cell Science · doi:10.1242/jcs.106.1.423 · Cited by 196
Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma
Turk, M. J., Waters, D. J., & Low, P. S. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.12.028 · Cited by 196
Shi, G., Guo, W., Stephenson, S. M., & Lee, R. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00017-2 · Cited by 192
Self-citationEndocytosis of GPI-linked membrane folate receptor-alpha.
Rijnboutt, S., Jansen, G., Posthuma, G., Hynes, J. B., Schornagel, J. H., & Strous, G. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.1.35 · Cited by 192
Low, Y. L. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0266-6 · Cited by 184
Leamon, C. P., Cooper, S. R., & Hardee, G. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020089t · Cited by 180
Preclinical Evaluation of EC145, a Folate-Vinca Alkaloid Conjugate
Reddy, J. A., Dorton, R., Westrick, E., Dawson, A., Smith, T., Xu, L.-C., Vetzel, M., Kleindl, P., Vlahov, I. R., & Leamon, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0033 · Cited by 176
Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors
Reddy, J. A., Abburi, C., Hofland, H., Howard, S. J., Vlahov, I., Wils, P., & Leamon, C. P. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301833 · Cited by 173
Shen, F., Wu, M., Ross, J. F., Miller, D., & Ratnam, M. (1995) · Biochemistry · doi:10.1021/bi00016a042 · Cited by 168
Lipidic Vector Systems for Gene Transfer
Lee, R. J., & Huang, L. (1997) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v14.i2.30 · Cited by 156
Self-citationEnhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation
Reddy, J. A., & Low, P. S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00135-2 · Cited by 155
Antibody-directed enzyme prodrug therapy (ADEPT): a review
Niculescu-Duvaz, I., & Springer, C. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00032-x · Cited by 154
Zhao, X. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.005 · Cited by 153
Self-citation99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging.
Guo, W., Hinkle, G. H., & Lee, R. J. (1999) · PubMed · Cited by 144
Self-citationA novel pH-sensitive liposome formulation containing oleyl alcohol
Sudimack, J. J., Guo, W., Tjarks, W., & Lee, R. J. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00399-1 · Cited by 143
Self-citationTumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy
Xu, L., Pirollo, K. F., & Chang, E. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00324-8 · Cited by 142
A Folate Receptor?Targeted Lipid Nanoparticle Formulation for a Lipophilic Paclitaxel Prodrug
Stevens, P. J., Sekido, M., & Lee, R. J. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7667-5 · Cited by 140
Self-citationTransfection of Folate-Polylysine DNA Complexes: Evidence for Lysosomal Delivery
Mislick, K. A., Baldeschwieler, J. D., Kayyem, J. F., & Meade, T. J. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00035a002 · Cited by 139
Ebel, W., Routhier, E., Foley, B., Jacob, S. M., McDonough, J., Patel, R. K., Turchin, H. A., Chao, Q., Kline, J. B., Old, L. J., et al. (2007) · PubMed · Cited by 137
Gottschalk, S. M., Cristiano, R. J., Smith, L. C., & Woo, S. L. C. (1994) · PubMed · Cited by 133
Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles
Seow, W. Y., Xue, J. M., & Yang, Y. Y. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.039 · Cited by 132
Benns, J. M., Mahato, R. I., & Kim, S. N. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00513-2 · Cited by 131
Kim, S. H., Mok, H., Jeong, J. H., Kim, S. W., & Park, T. G. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050289f · Cited by 129
Pan, X. Q., Wang, H., & Lee, R. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022656105022 · Cited by 124
Self-citationFolate-receptor-targeted radionuclide imaging agents
Ke, C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.004 · Cited by 123
Folate‐maytansinoids: Target‐selective drugs of low molecular weight
Ladino, C. A., Chari, R. V. J., Bourret, L. A., Kedersha, N., & Goldmacher, V. S. (1997) · International Journal of Cancer · Cited by 120
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes
van Steenis, J. H., van Maarseveen, E. M., Verbaan, F. J., Verrijk, R., Crommelin, D. J. A., Storm, G., & Hennink, W. E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00361-9 · Cited by 118
Receptor-targeted gene delivery viafolate-conjugated polyethylenimine
Guo, W., & Lee, R. J. (1999) · AAPS PharmSci · doi:10.1208/ps010419 · Cited by 114
Self-citationIntracellular Delivery of Nanometric DNA Particles via the Folate Receptor
Dauty, E., Rémy, J.-S., Zuber, G., & Behr, J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0255182 · Cited by 113
Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
Reddy, J. A., Xu, L.-C., Parker, N. L., Vetzel, M., & Leamon, C. P. (2004) · PubMed · Cited by 113
Folate-Targeted Gene Transfer in Vivo
Hofland, H. E. J., Masson, C., Iginla, S., Osetinsky, I., Reddy, J. A., Leamon, C. P., Scherman, D., Bessodes, M., & Wils, P. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0604 · Cited by 112
Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy
Reddy, J. A., Dean, D. A., Kennedy, M. D., & Low, P. S. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990169e · Cited by 103
Ward, C. M., Pechar, M., Oupický, D., Ulbrich, K., & Seymour, L. W. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.296 · Cited by 100
Konda, S. D., WANG, S., Brechbiel, M. W., & Wiener, E. C. (2002) · Investigative Radiology · doi:10.1097/00004424-200204000-00005 · Cited by 98
Kelley, K. M. M., Rowan, B. G., & Ratnam, M. (2003) · PubMed · Cited by 97
Antibody directed enzyme prodrug therapy (ADEPT)
Bagshawe, K. D., Sharma, S. K., Springer, C. J., & Rogers, G. T. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058725 · Cited by 96
Wang, H., Zheng, X., Behm, F. G., & Ratnam, M. (2000) · Blood · doi:10.1182/blood.v96.10.3529 · Cited by 88
Kranz, D. M., Patrick, T., Brigle, K. E., Spinella, M. J., & Roy, E. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9057 · Cited by 86
Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
Ni, S., Stephenson, S. M., & Lee, R. J. (2002) · PubMed · Cited by 83
Self-citationZhao, X. B., Muthusamy, N., Byrd, J. C., et al. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20885 · Cited by 80
Self-citationLu, J., Lowe, D., Kennedy, M. D., & Low, P. S. (1999) · Journal of drug targeting · doi:10.3109/10611869909085491 · Cited by 75
Lu, Y. J., Sega, E. I., & Low, P. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21126 · Cited by 73
Tran, T., Shatnawi, A. A., Zheng, X., Kelley, K. M. M., & Ratnam, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2890 · Cited by 72
Elgqvist, J., Andersson, H., Bäck, T. A., Hultborn, R., Jensen, H. J., Karlsson, B., Lindegren, S., Palm, S., Warnhammar, E., & Jacobsson, L. (2005) · PubMed · Cited by 72
Melani, C. C., Figini, M., Nicosia, D., Luison, E., Ramakrishna, V., Casorati, G., Parmiani, G., Eshhar, Z., Canevari, S., & Colombo, M. P. (1998) · PubMed · Cited by 64
Rait, A. S., Pirollo, K. F., Xiang, L., Ulick, D., & Chang, E. H. (2002) · Molecular Medicine · doi:10.1007/bf03402027 · Cited by 61
Properties of a Folate Binding Protein (FBP) isolated from porcine kidney
Kamen, B. A., & Caston, J. D. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90458-2 · Cited by 58
Suzuki, T., Hisakawa, S., Itoh, Y., Suzuki, N., Takahashi, K., Kawahata, M., Yamaguchi, K., Nakagawa, H., & Miyata, N. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.040 · Cited by 57
Lu, Y., Wu, J. H., Wu, J., Gonit, M., Yang, X., Lee, A., Xiang, G., Li, H., Liu, S., Marcucci, G., et al. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070058l · Cited by 56
Self-citationIncorporation of Reversibly Cross-Linked Polyplexes into LPDII Vectors for Gene Delivery
Gosselin, M. A., Guo, W., & Lee, R. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025512c · Cited by 54
Self-citationVarghese, B., Haase, N., & Low, P. S. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0700615 · Cited by 53
Folate-Mediated Targeting of Antisense Oligodeoxynucleotides to Ovarian Cancer Cells
Li, S., Deshmukh, H. M., & Huang, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011946915209 · Cited by 49
Targeted delivery of catalase and superoxide dismutase to macrophages using folate
Lee, S., & Murthy, N. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.054 · Cited by 44
Kim, S. H., Jeong, J. H., Mok, H., Lee, S. H., Kim, S. W., & Park, T. G. (2006) · Biotechnology Progress · doi:10.1021/bp060243g · Cited by 44
Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy.
Stephenson, S. M., Yang, W., Stevens, P. J., Tjarks, W., Barth, R. F., & Lee, R. J. (2003) · PubMed · Cited by 42
Self-citationStructure and regulation of a polymorphic gene encoding folate receptor type gamma/gamma'
Wang, H. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.9.2132 · Cited by 36
Folate-mediated targeting of T cells to tumors
Roy, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.006 · Cited by 35
Pan, X. Q., & Lee, R. J. (2005) · PubMed · Cited by 35
Self-citationChiu, S. J., Marcucci, G., & Lee, R. J. (2006) · PubMed · Cited by 31
Self-citationBispecific agents target endogenous murine T cells against human tumor xenografts
Rund, L. A., Cho, B. K., Manning, T. C., Holler, P. D., Roy, E. J., & Kranz, D. M. (1999) · International Journal of Cancer · Cited by 26
Cited by
Controlled drug delivery vehicles for cancer treatment and their performance
Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167
Applications of nanoparticle systems in drug delivery technology
Rizvi, S. A. A., & Saleh, A. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.10.012 · Cited by 1,334
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
Van Straten, D., Mashayekhi, V., De Bruijn, H., Oliveira, S., & Robinson, D. (2017) · Cancers · doi:10.3390/cancers9020019 · Cited by 1,012
Insight into nanoparticle cellular uptake and intracellular targeting
Yameen, B., Choi, W. I., Vilos, C., Swami, A., Shi, J., & Farokhzad, O. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.038 · Cited by 787
Subcellular targeting strategies for drug design and delivery
Rajendran, L., Knölker, H.-J., & Simons, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2897 · Cited by 708
Metadata
- Authors
- Zhao, X., Li, H., & Lee, R. J.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2008-03
- Volume
- 5
- Issue
- 3
- Pages
- 309-319
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2060882819
- Cited by
- 358
- References
- 91
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.